Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.
It's wrong. It says it was last changed on 28 Apr 2022 when it fell below 0.5%.
I'm expecting data to come out in August IMO
Trading viewpoint. We hit the 50 daily moving average at 102, and on the 30 min, 45 mins and hour view point we have strong support at 102. Expect to see a bounce IMO
Hi Toukankahmoon,
$AVCT isn’t #AVCT. It’s American Virtual Cloud Technology, completely different it entity. But if we were on Nasdaq and LSE platforms at the same time, they would tend to follow each other but not exactly. I hope that helps
Good to hear from you MyLuck. I was indeed around from Rich Ken days. Hope all is well with you.
Its always a great feeling riding a share that has gone up from the 50p to 140p thanks to some terrific news flow (Al’s terrific presentation, AACR poster and I mustn’t forget the AffyXell milestone, with an increased equity stake.
Yet as soon as the SP retraces, doubts surface, emotions rise, PIs start bickering, and all of a sudden, your finger is hovering over the sell button.
This is a typical PI (including myself) and that is why the majority of the time, PIs loose against the market.
When this happens, always review why you invested in the company in the first place. Has your investment appetite changed? Has the Investment case changed? Are you being influenced by your nerves/emotions? Are you being influenced by others?
If there is any bad news, Avacta would have to immediately provide a RNS and let the market aware of the pause of the trial. This hasn’t happened. In fact, someone posted today that we are over 240 days of the trail with no pause.
DE2 is expected to happen any day now which will further strengthen the investment case. People may have been expecting it earlier, but perhaps they are reviewing more data and considering whether they need a further DE if the results are so superior to get the job done?
Who knows. Everyone has their own opinion based on their own bias.
For me, facts are key and I believe all the facts are pointing to a positive PK read out that will be mind blowing.
I’m a long term investor who believes Avacta will become a multi billion company this year with the expectation of being bought out after the read out. That’s my view and I hold strong.
Just think that if Avacta can pull this off, millions of lives will be saved and improved. Isn’t that incredible.
For clarity, I didn’t enter at the lows , my average is over £1.40 and I’ve been holding for nearly 2 years. It’s been one hell of a roller coaster, but I have learnt many things.
Regardless of your position, I wish you well.
*Look
For those who have a short memory.. I like forward to hearing about DE2 if it comes next week or the week after
Just remember this..
They ca have my shares for £16+
It's blue sky. I think many PIs have their own opinion and value for what its worth. I strongly believe it will catapult us into the B's IMO. Thankfully, many Biotech companies/investment firms that specialises in this area will be providing their valuation on Avacta. If the data replicates pre-clinical, sadly I don't think Avacta will be around in 2023
I would think they will release the data late July/August/Early Sept
Glad to have you back to Robbo
Bump
What better way to start the financial year and to restore confidence in the company by declaring a cornerstone investor beyond £1. On top of that, ISAs will be lock and loaded for the new year. GLA
If it doesn’t show Nominee accounts then that could explain why MM is not on that list. i believe MM who has invested a lot of time trying to educate PIs on Avacta over the past few years
We know the agenda of these trolls/shorters. There is no point in wasting energy trying to talk to them. They win if that’s the case. Just sit back and remember why you invested in the first place
Thanks all! Some great points. Have a good Sunday
This is taken and expanded from Energyshares and The Ethical Trout on Twitter who both reminds us of all the opportunists that Avacta have.
AVA6000 works and is gaining pace.
Is it safe?
“Yes, the SDMC has positively reviewed the safety data”
Is it consistent?
“The data is remarkably consistent… across very different patient types”
What are the side effects?
A 50% DE indicates a Grade 1 CTCAE event: “mild or asymptomatic symptoms”
This data is expected to be released over the next 5-6 months. Key markers for it will be increasing DE and bringing on new hospitals. People forget that no news is good news.
The value of AVA6000 when on the market will be priced from £2bn to +£5bn (if successful). We hold the IP to the PRE-cision platform. Imagine how much the large biotechs will pay for the platform. These figures do sound mythical, but then so does toxic free chemo…
Avacta also have a multi-target deal with LG Chem worth up to $400m which has reached a pre-clinical development milestone payment.
A therapeutic division?Oncology x 11?Ava6000,AVA7500,?AVA028,AVA7000,AVA004?AVA027,AVA3996 plus 4 undisclosed targets?Not forgetting T Mac platform.
A joint venture in South Korea with Daewoong Pharmaceutical focused on cell and gene therapies incorporating Affimer immune-modulators and a collaboration with Point Biopharma to develop radiopharmaceuticals based on the pre|CISION™ platform.
A research collaboration with ModernaTX, Inc. (formerly Moderna Therapeutics Inc
Not forgetting
Astrea ?
Biokit ?
Abcam ?
Bioserve
Diagnostics Division
Everyone saying it’s dead?But Avacta still have a Global agreement with Medusa19 Meduflow HUA.?Affidx brand of a in house pipeline non-COVID diagnostic tests, which include assays for D-dimer, cortisol, vitamins D and B12 and CRP.
Stop engaging in the de-rampers who are out in force. They will become more and more aggressive when the margin is becoming smaller and smaller. Shorters have to buy back in at some point.
Just remember why you invested in the stock in the first place and sit back. In 6 months time, the SP will be much higher than it is now. I do hope that the shorters are still short to see the wrath of the positive sentiment return when people realise the true value of Avacta.
Until then, I do wish everyone well and thank you for those posters who are sharing their insight and knowledge across all platforms.
Always DYOR. GLA
Thanks MasterRSI!